Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

BACKGROUND: Checkpoint inhibitor-related pneumonitis (CIP) is a potentially fatal immune-related adverse event that occurs during treatment with immune checkpoint inhibitors (ICIs). However, the roles played by peripheral blood parameters in CIP development remain unclear. Here, we aimed to identify...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Lin, Xinqing, Deng, Haiyi, Yang, Yilin, Wu, Jianhui, Qiu, Guihuan, Li, Suyang, Xie, Xiaohong, Liu, Ming, Xie, Zhanhong, Qin, Yinyin, Song, Yong, Zhou, Chengzhi
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313853/
https://ncbi.nlm.nih.gov/pubmed/34327140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.698832
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares